Visit the TerrAscend Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
TORONTO, Nov. 14, 2017 (GLOBE NEWSWIRE) — TerrAscend Corp. (CSE:TER) (“TerrAscend” or the “Company”) announces a change of Chief Financial Officer (“CFO”). Mr Roland Nimmo has replaced Ms. Rebecca Hudson in the capacity as Interim CFO. The Company would like to thank Ms. Hudson for her service and professionalism throughout her time with TerrAscend. Roland is a seasoned financial professional and has been a trusted advisor to numerous decision-makers in some of Canada’s largest, most prominent corporations. Roland holds an Honours Degree of Economics from Queens University and is a CPA, CA.
TerrAscend is a vertically-integrated Canadian cannabis company that strives to create and deliver quality products and services that meet the evolving needs of the cannabis market. The Company provides support to patients through its wholly-owned subsidiaries, Solace Health Inc. (“Solace Health”), a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations, Terra Health Network Inc. (“Terra Health”), a clinical support program and education platform led by health care professionals, and Solace Rx Inc. (“SolaceRx”), a drug preparation premises for non-cannabis formulations. Please visit www.TerrAscend.com for more information about the Company.
The most reliable, fact-based information on TerrAscend found only on its Investor Dashboard.
Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.